JP2022517517A5 - - Google Patents
Info
- Publication number
- JP2022517517A5 JP2022517517A5 JP2021534294A JP2021534294A JP2022517517A5 JP 2022517517 A5 JP2022517517 A5 JP 2022517517A5 JP 2021534294 A JP2021534294 A JP 2021534294A JP 2021534294 A JP2021534294 A JP 2021534294A JP 2022517517 A5 JP2022517517 A5 JP 2022517517A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- glioma
- day
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18382917.5A EP3666266A1 (en) | 2018-12-12 | 2018-12-12 | Treatment and prevention of glioblastoma |
| EP18382917.5 | 2018-12-12 | ||
| PCT/EP2019/084822 WO2020120656A1 (en) | 2018-12-12 | 2019-12-12 | Treatment and prevention of glioblastoma |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022517517A JP2022517517A (ja) | 2022-03-09 |
| JP2022517517A5 true JP2022517517A5 (cg-RX-API-DMAC7.html) | 2022-12-20 |
| JP7746157B2 JP7746157B2 (ja) | 2025-09-30 |
Family
ID=64746483
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021534294A Active JP7746157B2 (ja) | 2018-12-12 | 2019-12-12 | 膠芽腫の治療および予防 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US12622884B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP3666266A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7746157B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN113365619A (cg-RX-API-DMAC7.html) |
| CA (1) | CA3122640A1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2986469T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020120656A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES3048032B2 (es) * | 2025-05-27 | 2026-07-23 | Univ Madrid Complutense | N-(4-Ariloxi-3-hidroxibutan-2-il)alcanamidas con actividad antagonista adrenérgica beta-2 selectiva |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015121500A1 (en) * | 2014-02-17 | 2015-08-20 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Pharmaceutical compositions for use in the treatment of ventilator-induced diaphragmatic dysfunction |
| EA202090452A1 (ru) | 2017-08-07 | 2020-06-15 | Консехо Супериор Де Инвестигасионес Сьентификас | Соединения для лечения болезни фон гиппеля-линдау |
| CN115715804A (zh) | 2019-03-05 | 2023-02-28 | 阿尔加克蒂夫有限公司 | 类胡萝卜素在衰老相关疾病的治疗中的用途 |
| CN112804996B (zh) | 2019-03-05 | 2025-01-14 | 加特治疗有限公司 | 类胡萝卜素在衰老相关疾病的治疗中的用途 |
-
2018
- 2018-12-12 EP EP18382917.5A patent/EP3666266A1/en not_active Withdrawn
-
2019
- 2019-12-12 US US17/413,500 patent/US12622884B2/en active Active
- 2019-12-12 JP JP2021534294A patent/JP7746157B2/ja active Active
- 2019-12-12 EP EP19829028.0A patent/EP3893861B1/en active Active
- 2019-12-12 CN CN201980091073.7A patent/CN113365619A/zh active Pending
- 2019-12-12 CA CA3122640A patent/CA3122640A1/en active Pending
- 2019-12-12 WO PCT/EP2019/084822 patent/WO2020120656A1/en not_active Ceased
- 2019-12-12 ES ES19829028T patent/ES2986469T3/es active Active